Medical Oncologist
CION Cancer Clinics
BRCA1 versus BRCA2: how the cancer risks actually differ | CION Cancer Clinics
Both genes carry a high lifetime risk of breast cancer, and by old age the two figures are close. The real differences lie elsewhere. BRCA1 brings a higher ovarian cancer risk that starts earlier, while BRCA2 matters more for men, especially for prostate cancer. This page sets the two side by side and explains how the gene named on your report changes the plan. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
Is BRCA1 riskier than BRCA2?
For breast cancer, the lifetime risk is high with both and broadly similar. The big differences are elsewhere. BRCA1 carries a clearly higher ovarian cancer risk that starts earlier, and BRCA2 matters more for men.
Two genes, one job
Both genes help a cell repair a particular kind of DNA break. When one copy is faulty from birth, cells in the breast, ovary and a few other organs are more likely to build up the damage that leads to cancer. That shared job is why the two are usually tested together and often spoken of as one.
Why the difference is worth knowing
The gene named on your report shapes real decisions. It affects when removal of the ovaries is discussed, what kind of breast cancer is more likely, and how closely the men in the family should be watched. Treating the two as identical can mean acting too early for one and too late for the other.
What stays the same with either gene
Each child of a carrier has an even chance of inheriting the fault, whichever gene it is. The fault can come through a father as easily as a mother. Relatives are tested only for the exact fault already found, which is a simpler test than the first one.
Risk figures vary between studies and between families. Your counsellor will put your own family history beside them.Cancer by cancer
Where do the two genes differ most?
Figures below are from the US National Cancer Institute, written as plain proportions.
Breast cancer
High with both genes. Roughly half to seven in ten women with either fault develop breast cancer by old age. BRCA1 cancers tend to appear younger.
The type often differs
- BRCA1: often triple negative
- BRCA2: usually hormone sensitive
Ovarian cancer
The clearest difference. About two in five women with BRCA1 develop ovarian cancer by old age, against fewer than one in five with BRCA2. With BRCA1 it also tends to appear earlier. There is no reliable screening test for ovarian cancer, which is why this gap weighs so heavily in planning.
Cancers in men
Male breast cancer and prostate cancer are both more strongly linked to BRCA2. Prostate cancer in BRCA2 carriers can also behave more aggressively, which is why earlier checks are discussed. Men are also the relatives most often left out of family testing.
Other cancers
Pancreatic cancer risk is raised with both, more consistently with BRCA2. A link with melanoma has been reported for BRCA2, though the evidence is less firm.
What the gene changes
How does BRCA1 or BRCA2 change the plan?
Breast screening
Much the same for both. Yearly breast MRI starts young, long before routine mammograms, and mammograms are added later. The start age is set by your team.
Timing of ovary removal
Because ovarian risk rises earlier with BRCA1, removal of the ovaries and tubes is usually discussed a few years sooner than for BRCA2. It is one option among several, and only once childbearing is complete.
Treatment if cancer develops
Both faults can make a cancer respond to PARP inhibitor tablets and to platinum chemotherapy. The gene alone does not decide this. The whole picture of the cancer does.
Checks for men
Men with BRCA2 are usually offered earlier prostate checks and breast awareness. For men with BRCA1 the extra risk is smaller, and advice depends more on family history.
Not sure whether this applies to you?
Ask an oncologistOn your report
The words you will meet, in plain language
- Lifetime risk
- The chance of developing a cancer by old age. It is an average across many carriers, not a forecast for one person.
- Triple negative
- A breast cancer that lacks the three receptors most treatments target. It is more common with BRCA1.
- Hormone sensitive
- A breast cancer that grows in response to oestrogen. Most BRCA2 breast cancers are this type.
- Penetrance
- How often a fault actually leads to cancer across everyone who carries it. It is never all of them.
- PARP inhibitor
- A tablet that targets cancers with faulty BRCA repair. It is a treatment choice, covered on the targeted therapy pages.
- Pathogenic variant
- A spelling change known to break the gene. This is what people mean by a BRCA mutation.
Side by side
BRCA1 and BRCA2 at a glance
BRCA1
BRCA2
High breast risk, often at a younger age
High breast risk, often a little later
Higher ovarian risk that starts earlier
Lower ovarian risk that starts later
Small extra risk for men
Clear extra prostate and male breast risk
Some raised pancreatic risk
More consistently raised pancreatic risk
Commonly believed
Four things families tell us, and what is actually true
"BRCA2 is the mild one, so we can relax."
Breast cancer risk with BRCA2 is still high, and close to that of BRCA1 by old age. BRCA2 also raises risk for men. It calls for a plan just as much.
"BRCA is a women's problem."
Men carry and pass on both faults exactly as women do. A father can pass a fault to a daughter. Men with BRCA2 have their own raised risk of prostate and breast cancer.
"My mother had BRCA1, so I will get ovarian cancer."
First you need a test, because each child has an even chance of not inheriting the fault. Even with the fault, most carriers never develop ovarian cancer, and options exist to lower the risk further.
"Both genes need exactly the same plan."
Breast screening is much the same. The timing of ovary surgery and the checks offered to men differ, which is why the gene name on the report matters.
Being straight with you
What this page cannot tell you
It cannot give you your own risk. The figures here are averages from large studies, mostly in European and American families. Studies in Indian families are growing but are still small, and risk also depends on the exact variant and on your family history.
It cannot read your report
Two people with BRCA1 faults can be advised differently. What your specific variant means is a question for the counsellor who ordered the test. Please bring the report rather than searching the variant name online.
Who this does not apply to
This page is about germline faults, present from birth. If a BRCA fault was found only in tumour tissue, it may not be inherited, and that result belongs with your cancer team and the targeted therapy pages. If your report shows a variant of uncertain significance, these risks do not apply either. Counselling can take place in Telugu.
Unsure which gene your family carries? Call the helpline and someone will help you find the original report.Questions we are asked
Common questions about BRCA1 and BRCA2
Which is more common in India, BRCA1 or BRCA2?
Several Indian studies of women tested after breast or ovarian cancer have found BRCA1 faults more often than BRCA2. The pattern varies by region and community, and the studies are still fairly small, so it should not change how either result is handled.
Does BRCA1 breast cancer have a worse outlook?
Not simply because of the gene. BRCA1 cancers are more often triple negative, which is treated differently, but many respond well to chemotherapy. Outlook depends on stage and type at diagnosis, which is why early screening matters so much.
Can someone carry both a BRCA1 and a BRCA2 fault?
Yes, though it is uncommon. It is seen more in communities where a founder fault is frequent and in families where parents are related. Each fault is inherited separately, so relatives may carry one, both or neither.
When should the ovaries be removed?
Guidelines suggest discussing it somewhat earlier for BRCA1 than for BRCA2, and only once you have finished having children. It is a major decision with lasting effects. Your gynaecologist and counsellor will talk through the timing and the alternatives.
My brother has BRCA2. What should he do?
He should discuss earlier prostate checks and breast awareness with his doctor. He should also know that his children each have an even chance of inheriting the fault. His daughters in particular may want testing as adults.
Is screening the same for both genes?
Breast screening is broadly the same, with MRI starting young. The differences lie in ovarian planning and in checks for men. Your team will write a schedule for your exact gene.
Do PARP inhibitors work for both?
They are used for cancers linked to either gene. Whether they suit a particular cancer depends on its type, stage and earlier treatment. Your oncologist makes that call, and the targeted therapy pages explain the medicines in detail.
Should my children be tested now?
Usually not in childhood. The risks linked to both genes start in adult life, so testing normally waits until your child is an adult and can choose. Nothing about childhood care changes either way.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — BRCA Gene Changes: Cancer Risk and Genetic Testing
- GeneReviews (NCBI) — BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
- MedlinePlus Genetics — BRCA1 gene
- MedlinePlus Genetics — BRCA2 gene
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Want your family's result explained properly?
Bring the report and a rough family tree. We will help you reach a genetics team who can explain what the named gene means for you and your relatives. One helpline serves every CION centre.